Henry Lik Yuen Chan
0000-0002-7790-1611
8 papers found
Refreshing results…
Improvement in enhanced liver fibrosis score and liver stiffness measurement reflects lower risk of hepatocellular carcinoma
Editorial: a baseline tool for predicting response to peginterferon alfa-2a in HBeAg-positive patients-same score, different outcomes. Author's Reply
Switching to Peginterferon for Chronic Hepatitis B Patients with Hepatitis B e Antigen Seroconversion on Entecavir - A Prospective Study
Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health-related quality of life in East Asian patients with hepatitis C virus infection
Chronic kidney disease progression in patients with chronic hepatitis B on tenofovir, entecavir, or no treatment
A baseline tool for predicting response to peginterferon alfa-2a in HBeAg-positive patients with chronic hepatitis B
Review article: long-term safety of oral anti-viral treatment for chronic hepatitis B
Statins reduce the risk of liver decompensation and death in chronic viral hepatitis: a propensity score weighted landmark analysis
Missing publications? Search for publications with a matching author name.